How long should patients remain on lebrikizumab to achieve optimal long-term control of their atopic dermatitis symptoms?
Featuring Alexandra Golant, MD |
Medical Director, Dermatology Faculty Practice
Associate Director, Residency Program
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Related Media
Powered by Polaris TM